Advancing Durable Medicines For Unmet Needs

Centaro Biosciences is a clinical-stage biotechnology company developing innovative medicines to address critical unmet medical needs in resource-limited regions. We focus on diseases where treatment success depends not only on biological activity, but on maintaining therapeutic exposure over meaningful clinical timeframes.

Our programmes are designed to improve real-world effectiveness by reducing reliance on frequent dosing and perfect adherence. By combining validated human biology, translational pharmacology, and clinically practical dosing strategies, Centaro advances drug candidates intended to deliver durable outcomes in healthcare environments where conventional therapies often fall short.